title: Ledipasvir/Sofosbuvir administration achieves very high rate of viral clearance in patients with HCV genotype 1 infection without cirrhosis, regardless of ribavirin co-administration or length of treatment.
authors.affiliation: Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Naples, Italy.
authors.forename: Ivan
authors.initials: I
authors.lastname: Gentile
authors.affiliation: Department of Clinical Medicine and Surgery, Section of Infectious Diseases, University of Naples Federico II, Naples, Italy.
authors.forename: Guglielmo
authors.initials: G
authors.lastname: Borgia
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D001562:Benzimidazoles / Q000627:therapeutic use*; D005260:Female; D005449:Fluorenes / Q000627:therapeutic use*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D008297:Male; D014542:Uridine Monophosphate / Q000031:analogs & derivatives*
chemical_list: D000998:Antiviral Agents; D001562:Benzimidazoles; D005449:Fluorenes; D014542:Uridine Monophosphate
keywords: GASTROENTEROLOGY; INFECTIOUS DISEASES; STATISTICS & RESEARCH METHODS